NCT02471846 2019-10-22A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Completed158 enrolled
NCT02048709 2017-02-06Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid TumorsGenentech, Inc.Phase 1 Completed22 enrolled